Compare RXRX & ARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RXRX | ARR |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.8B |
| IPO Year | 2021 | 2009 |
| Metric | RXRX | ARR |
|---|---|---|
| Price | $2.45 | $10.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $6.77 | ★ $15.56 |
| AVG Volume (30 Days) | ★ 21.1M | 4.5M |
| Earning Date | 11-02-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 26.59% |
| EPS Growth | 14.79 | ★ 747.06 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $74,681,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.23 | $18.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 26.92 | N/A |
| 52 Week Low | $2.50 | $10.36 |
| 52 Week High | $5.24 | $19.31 |
| Indicator | RXRX | ARR |
|---|---|---|
| Relative Strength Index (RSI) | 30.58 | 24.49 |
| Support Level | N/A | N/A |
| Resistance Level | $3.66 | $17.59 |
| Average True Range (ATR) | 0.29 | 0.40 |
| MACD | -0.12 | -0.11 |
| Stochastic Oscillator | 0.31 | 18.71 |
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.